MBX Biosciences, Inc. Common Stock (MBX) — Financial Flexibility Index
MBX Biosciences, Inc. Common Stock (MBX) has a Financial Flexibility Index of -1.32x as of March 2026. Free cash flow of $-19.77 Million (operating CF $-20.21 Million minus capex $437.00K) represents -1% of total liabilities ($14.95 Million). Check asset resilience ratio of MBX Biosciences, Inc. Common Stock to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
MBX Biosciences, Inc. Common Stock Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for MBX Biosciences, Inc. Common Stock across 4 annual periods. See MBX Biosciences, Inc. Common Stock current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for MBX Biosciences, Inc. Common Stock (2022–2025)
Year-by-year free cash flow to debt coverage for MBX Biosciences, Inc. Common Stock. For the full company profile including market capitalisation, see market value of MBX Biosciences, Inc. Common Stock.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.90x | $-78.02 Million | $-79.95 Million | $15.92 Million | ▼ -1.0% |
| 2024 | -4.85x | $-53.81 Million | $-54.68 Million | $11.09 Million | ▼ -2285.7% |
| 2023 | -0.20x | $-31.85 Million | $-31.98 Million | $156.65 Million | ▲ +21.4% |
| 2022 | -0.26x | $-22.68 Million | $-23.12 Million | $87.70 Million | — |